01477.HK
Ocumension Therapeutics
HKSE · Healthcare · Biotechnology · CN
HKD 5.37
+1.23%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 14.18x
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.04x
- Price / sales
- 2.56x
- Price / cash flow
- -35.79x
Enterprise value
- Enterprise value
- HKD 4.4B
- EV / sales
- 2.57x
- EV / EBITDA
- -14.79x
- EV / EBIT
- -9.40x
- Market cap
- HKD 4.4B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026